{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:17:11Z","timestamp":1789089431958,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jhep.2015.01.004","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T05:51:54Z","timestamp":1421214714000},"page":"1391-1397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure"],"prefix":"10.1016","volume":"62","author":[{"given":"Annika","family":"Mutanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Lohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Heikkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Jalanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko P.","family":"Pakarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.01.004_b0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005176-200403000-00006","article-title":"Irreversible intestinal failure","volume":"38","author":"Goulet","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2015.01.004_b0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2007-985070","article-title":"Intestinal failure-associated liver disease: management and treatment strategies past, present, and future","volume":"27","author":"Carter","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2015.01.004_b0015","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1053\/j.gastro.2005.10.066","article-title":"Intestinal failure-associated liver disease: what do we know today?","volume":"130","author":"Kelly","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.004_b0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.26360","article-title":"Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure","volume":"58","author":"Mutanen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0025","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.25500","article-title":"Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury","volume":"55","author":"El Kasmi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0030","doi-asserted-by":"crossref","first-page":"206ra137","DOI":"10.1126\/scitranslmed.3006898","article-title":"Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease","volume":"5","author":"El Kasmi","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2015.01.004_b0245","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jhep.2014.06.025","article-title":"Altered FXR signaling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease","volume":"61","author":"Pereira-Fantini","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.004_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jhep.2015.01.004_b0045","doi-asserted-by":"crossref","first-page":"G940","DOI":"10.1152\/ajpgi.00398.2012","article-title":"Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids","volume":"304","author":"Zhang","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.01.004_b0050","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2015.01.004_b0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1101\/sqb.2011.76.010710","article-title":"Roles of FGF19 in liver metabolism","volume":"76","author":"Kir","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.jhep.2015.01.004_b0060","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm1501","article-title":"Identification of a hormonal basis for gallbladder filling","volume":"12","author":"Choi","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2015.01.004_b0065","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/ibd.21502","article-title":"Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers","volume":"17","author":"Lenicek","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2015.01.004_b0070","doi-asserted-by":"crossref","first-page":"e67160","DOI":"10.1371\/journal.pone.0067160","article-title":"Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease","volume":"26","author":"Alisi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.01.004_b0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.004_b0080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.dld.2010.01.003","article-title":"Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition","volume":"42","author":"Pakarinen","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2015.01.004_b0085","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/MPG.0b013e3182474118","article-title":"Parenteral plant sterols and intestinal failure-associated liver disease in neonates","volume":"54","author":"Kurvinen","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2015.01.004_b0250","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3945\/ajcn.114.088781","article-title":"Serum plant sterols, cholestanol, and cholesterol precursors associate with histological liver injury in pediatric onset intestinal failure","volume":"100","author":"Mutanen","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhep.2015.01.004_b0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0022-3468(96)90507-2","article-title":"Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors","volume":"31","author":"Beath","year":"1996","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2015.01.004_b0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpedsurg.2009.10.020","article-title":"Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome","volume":"45","author":"Fitzgibbons","year":"2010","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2015.01.004_b0105","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jpedsurg.2009.01.031","article-title":"Establishing norms for intestinal length in children","volume":"44","author":"Struijs","year":"2009","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2015.01.004_b0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07853890.2010.515603","article-title":"New Finnish growth references for children and adolescents aged 0 to 20years: length\/height-for-age, weight-for-length\/height, and body mass index-for-age","volume":"43","author":"Saari","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.jhep.2015.01.004_b0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-2275(20)38566-7","article-title":"Cholesterol metabolism during ketoconazole treatment in man","volume":"29","author":"Miettinen","year":"1988","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.01.004_b0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0130","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.01.004_b0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.01.004_b0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.24702","article-title":"The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract","volume":"55","author":"Zweers","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"Lundasen","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.jhep.2015.01.004_b0155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","article-title":"A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis","volume":"7","author":"Walters","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.01.004_b0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2015.01.004_b0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/mp700105z","article-title":"Mini-review: endocrine actions of fibroblast growth factor 19","volume":"5","author":"Jones","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jhep.2015.01.004_b0170","doi-asserted-by":"crossref","first-page":"247ra100","DOI":"10.1126\/scitranslmed.3009098","article-title":"A nontumorigenic variant of FGF19 treats cholestatic liver diseases","volume":"30","author":"Luo","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2015.01.004_b0175","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0180","doi-asserted-by":"crossref","first-page":"G440","DOI":"10.1152\/ajpgi.00322.2009","article-title":"The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance","volume":"298","author":"Schreuder","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.01.004_b0185","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1194\/jlr.M044545","article-title":"New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs","volume":"55","author":"Vlaardingerbroek","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.01.004_b0190","doi-asserted-by":"crossref","first-page":"G218","DOI":"10.1152\/ajpgi.00280.2011","article-title":"Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs","volume":"302","author":"Jain","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.01.004_b0195","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0030-1253227","article-title":"The role of inflammation in cholestasis: clinical and basic aspects","volume":"30","author":"Kosters","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2015.01.004_b0200","first-page":"1273","article-title":"Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis","volume":"22","author":"Whiting","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0205","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/014860719501900180","article-title":"Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat","volume":"19","author":"Pappo","year":"1995","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.jhep.2015.01.004_b0210","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jpedsurg.2007.01.071","article-title":"Two-hit rat model of short bowel syndrome and sepsis: independent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver","volume":"42","author":"Aprahamian","year":"2007","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2015.01.004_b0215","first-page":"50","article-title":"Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis","volume":"32","author":"El-Faramawy","year":"2011","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jhep.2015.01.004_b0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000339960","article-title":"Early inflammatory markers for prediction of cholestasis in very-low-birth-weight infants","volume":"102","author":"DeMauro","year":"2012","journal-title":"Neonatology"},{"key":"10.1016\/j.jhep.2015.01.004_b0225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0148607195019006453","article-title":"Parenteral nutrition is associated with intestinal morphologic and functional changes in humans","volume":"19","author":"Buchman","year":"1995","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.jhep.2015.01.004_b0230","doi-asserted-by":"crossref","first-page":"G348","DOI":"10.1152\/ajpgi.90233.2008","article-title":"Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome","volume":"296","author":"Tian","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.01.004_b0235","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/01.CCM.0000053523.73064.8A","article-title":"Alteration in epithelial permeability and ion transport in a mouse model of total parenteral nutrition","volume":"31","author":"Yang","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2015.01.004_b0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1203\/PDR.0b013e3181256492","article-title":"Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR","volume":"62","author":"Carter","year":"2007","journal-title":"Pediatr Res"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T20:11:58Z","timestamp":1651003918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0168827815000070"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.01.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.03.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}